Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Investor Eye: Juno Capital Believes Medtech Is An Optimal Long-Term Investment

Executive Summary

Juno Capital partner Edward Rudd believes that investing in medtech offers not only a long-term strategy for allocating capital, but an altruistic relief for investors.

You may also be interested in...



Minute Insight: FDA Clears Sky Medical’s Latest Blood Flow-Boosting Geko Device

The Geko W3 is a wearable device that increases blood flow to treat venous insufficiency and/or ischaemia.

Minute Insight: Olympus Corporation Joins VC Race With Its Own Fund

The Japanese company is hoping to access breaking technologies sooner via earlier investment.

Getting A Head Start: Medtech VC Aims Earlier Than Ever Before

As the value of medtech deals increases, investors are increasingly looking for earlier opportunities. COVID-19 has added both impetus and new opportunity, with innovators and investors vying to build a position in digital health technologies, such as remote monitoring and digital therapeutics.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT143989

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel